Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Low ectonucleotidase activity and increased neutrophil-platelet aggregates in patients with antiphospholipid syndrome

Somanathapura K. NaveenKumar, Ajay Tambralli, Bruna Mazetto Fonseca, Srilakshmi Yalavarthi, Wenying Liang, Claire K. Hoy, Cyrus Sarosh, Christine E. Rysenga, Caroline H. Ranger, Caroline E. Vance, Jacqueline A. Madison, Fernanda A. Orsi, Suman L. Sood, Jordan K. Schaefer, Yu Zuo, Jason S. Knight

Blood (2024) 143 (12): 1193–1197.

https://doi.org/10.1182/blood.2023022097

Published: 2024

Includes: Supplemental data

Journal Articles

Emergency Department Utilization for Heavy Menstrual Bleeding (2016-2020): An Opportunity to Improve Care

Jennifer Girard, Jordan K Schaefer, Charley Jiang, Mana Yacim, Alexander Janke, Erica Marsh

Blood (2023) 142 (Supplement 1): 5120.

https://doi.org/10.1182/blood-2023-181912

Published: 2023

Journal Articles

Surveying Patients' Experiences and Perspectives on Venous Thromboembolism Care: An International Study to Identify Gaps and Opportunities in Health Care Delivery

Rushad Patell, Laura Dodge, Ang Li, Anna L Parks, Jordan K Schaefer, Alejandra Gutierrez Bernal, Shruti Chaturvedi, Anjlee Mahajan, Jori E. May, William Robertson, Leslie Lake, Dana E. Angelini

Blood (2023) 142 (Supplement 1): 5043.

https://doi.org/10.1182/blood-2023-181172

Published: 2023

Journal Articles

A Comparison of Bleeding Events Among Patients on Apixaban, Rivaroxaban, and Warfarin for Atrial Fibrillation and/or Venous Thromboembolism

Jordan K Schaefer, Josh Errickson, Xiaowen Kong, Mona A Ali, Naina Chipalkatti, Brian Haymart, Scott Kaatz, Gregory D Krol, Suman L Sood, James Froehlich, Geoffrey D. Barnes

Blood (2023) 142 (Supplement 1): 135.

https://doi.org/10.1182/blood-2023-184457

Published: 2023

Journal Articles

Outcomes of Oral Anticoagulation with Concomitant NSAID Use: A Registry Based Cohort Study

Jordan K Schaefer, Josh Errickson, Xiaowen Kong, Mona A Ali, Naina Chipalkatti, Paul Dorby, Christopher Giuliano, Brian Haymart, Scott Kaatz, Jacob E Kurlander, Gregory D Krol, Sahana Shankar, Suman L Sood, James Froehlich, Geoffrey D. Barnes

Blood (2023) 142 (Supplement 1): 5129.

https://doi.org/10.1182/blood-2023-184907

Published: 2023

Journal Articles

Monoclonal gammopathy of thrombotic/thrombocytopenic significance

Adam J. Kanack, Jordan K. Schaefer, Meera Sridharan, Noah P. Splinter, Mindy C. Kohlhagen, Bandana Singh, Silvana B. De Lorenzo, Emily E. Mauch, Maen A. Hussein, Marwan Shaikh, Shaji Kumar, Renren Wen, Demin Wang, David Murray, Anand Padmanabhan

Blood (2023) 141 (14): 1772–1776.

https://doi.org/10.1182/blood.2022018797

Published: 2023

Includes: Supplemental data

Journal Articles

Outcomes of Direct Oral Anticoagulants with Aspirin Versus Warfarin with Aspirin for Atrial Fibrillation and/or Venous Thromboembolic Disease

Jordan K Schaefer, Josh Errickson, Xiaowen Kong, Tina Alexandris-Souphis, Mona A Ali, Subhash Edupuganti, Brian Haymart, Scott Kaatz, Eva Kline-Rogers, Jay H Kozlowski, Gregory D Krol, Vinay Shah, Suman L Sood, James B Froehlich, Geoffrey D Barnes

Blood (2021) 138 (Supplement 1): 179.

https://doi.org/10.1182/blood-2021-146294

Published: 2021

Journal Articles

A Multi-Center Quality Improvement Intervention to Reduce the Inappropriate Use of Aspirin Among Patients Anticoagulated with Warfarin for Atrial Fibrillation or Venous Thromboembolism

Jordan K Schaefer, MD, Josh Errickson, PhD, Xiaokui Gu, MA, Tina Alexandris-Souphis, RN, Mona A Ali, PharmD, Brian Haymart, RN, MS, Scott Kaatz, DO, MSc, Eva Kline-Rogers, RN, MS, Jay H Kozlowski, MD, Gregory D Krol, Suman L Sood, MD, James B Froehlich, MD MPH, Geoffrey D Barnes, MD MSc

Blood (2019) 134 (Supplement_1): 788.

https://doi.org/10.1182/blood-2019-123067

Published: 2019

Journal Articles

Impact of Adding Aspirin to Direct Oral Anticoagulant Therapy without an Apparent Indication

Jordan K Schaefer, MD, Yun Li, PhD, Xiaowen Kong, MA, Tina Alexandris-Souphis, RN, Mona A Ali, PharmD, Brian Haymart, RN, MS, Scott Kaatz, DO, MSc, Eva Kline-Rogers, RN, MS, Jay H Kozlowski, MD, Gregory D Krol, Sahana R Shankar, Suman L Sood, MD, James B Froehlich, MD MPH, Geoffrey D Barnes, MD MSc

Blood (2019) 134 (Supplement_1): 787.

https://doi.org/10.1182/blood-2019-122526

Published: 2019

Journal Articles

Meta-Analysis and Cost-Effectiveness Analysis of Low-Dose Direct Oral Anticoagulant for the Prevention of Cancer Associated Thrombosis

Ang Li, MD, Josh J Carlson, PhD, Nicole M. Kuderer, Jordan K Schaefer, MD, Shan Li, PharmD, David A. Garcia, MD, Alok A Khorana, MD, Marc Carrier, MD, Gary H. Lyman, MD MPH

Blood (2019) 134 (Supplement_1): 4669.

https://doi.org/10.1182/blood-2019-127917

Published: 2019

Journal Articles

Practice and Correlates of Cancer Associated Thrombosis: The Impact of Socioeconomic Status

Jordan K. Schaefer, MD, Zhenke Wu, PhD, Mengbing Li, Jennifer J Griggs, MD MPH, Suman L. Sood, MD

Blood (2018) 132 (Supplement 1): 2225.

https://doi.org/10.1182/blood-2018-99-117931

Published: 2018

Journal Articles

The Impact of Adding Aspirin to Warfarin without an Apparent Indication: An Exploration of Patients Anticoagulated for Atrial Fibrillation or Venous Thromboembolic Disease

Jordan K. Schaefer, MD, Nicole M. Souphis, Suman L. Sood, MD MSCE, Brian Haymart, RN, MS, Xiaokui Gu, MA, Eva Kline-Rogers, RN, MS, Steven L. Almany, MD, Jay H. Kozlowski, MD, Gregory D. Krol, MD, Scott Kaatz, DO, MSc, James B. Froehlich, MD MPH, Geoffrey D. Barnes, MD MSc

Blood (2017) 130 (Supplement 1): 220.

https://doi.org/10.1182/blood.V130.Suppl_1.220.220

Published: 2017

Journal Articles

A Comparison of Socioeconomic Factors in Patients Continuing Warfarin Versus Those Transitioning to Direct Oral Anticoagulants (DOACs) for Venous Thromboembolic Disease or Atrial Fibrillation

Jordan K. Schaefer, MD, Suman L. Sood, MD MSCE, Brian Haymart, RN, MS, Xiaokui Gu, MA, Eva Kline-Rogers, RN, MS, Steven L. Almany, MD, Jay H. Kozlowski, MD, Gregory D. Krol, MD, Scott Kaatz, DO, MSc, James B. Froehlich, MD MPH, Geoffrey D. Barnes, MD MSc

Blood (2016) 128 (22): 1179.

https://doi.org/10.1182/blood.V128.22.1179.1179

Published: 2016

Journal Articles

Biomarkers and Clinical Prediction Rules in the Diagnosis of Suspected Deep Vein Thrombosis: A Comparison of Cancer and Non-Cancer Patients

Jordan K. Schaefer, MD, Dana E. Angelini, MD, Angela Hawley, MS, Susan A. Blackburn, RN, MBA, Elizabeth Lusk, Thomas M. Braun, PhD, Thomas W. Wakefield, MD, Suman L. Sood, MD MSCE

Blood (2016) 128 (22): 3804.

https://doi.org/10.1182/blood.V128.22.3804.3804

Published: 2016

Journal Articles

Improving Recognition, Diagnosis, and Management Of Heparin Induced Thrombocytopenia By Implementing a Computer-Based Clinical Decision Support System

Jordan K Schaefer, MD, Rajiv K Pruthi, MBBS, Jennifer S Shin, Mark W Dobie, Pedro J Caraballo, MD

Blood (2013) 122 (21): 2966.

https://doi.org/10.1182/blood.V122.21.2966.2966

Published: 2013

NARROW

Low ectonucleotidase activity and increased neutrophil-platelet aggregates in patients with antiphospholipid syndrome

Emergency Department Utilization for Heavy Menstrual Bleeding (2016-2020): An Opportunity to Improve Care

Surveying Patients' Experiences and Perspectives on Venous Thromboembolism Care: An International Study to Identify Gaps and Opportunities in Health Care Delivery

A Comparison of Bleeding Events Among Patients on Apixaban, Rivaroxaban, and Warfarin for Atrial Fibrillation and/or Venous Thromboembolism

Outcomes of Oral Anticoagulation with Concomitant NSAID Use: A Registry Based Cohort Study

Monoclonal gammopathy of thrombotic/thrombocytopenic significance

Outcomes of Direct Oral Anticoagulants with Aspirin Versus Warfarin with Aspirin for Atrial Fibrillation and/or Venous Thromboembolic Disease

A Multi-Center Quality Improvement Intervention to Reduce the Inappropriate Use of Aspirin Among Patients Anticoagulated with Warfarin for Atrial Fibrillation or Venous Thromboembolism

Impact of Adding Aspirin to Direct Oral Anticoagulant Therapy without an Apparent Indication

Meta-Analysis and Cost-Effectiveness Analysis of Low-Dose Direct Oral Anticoagulant for the Prevention of Cancer Associated Thrombosis

Practice and Correlates of Cancer Associated Thrombosis: The Impact of Socioeconomic Status

The Impact of Adding Aspirin to Warfarin without an Apparent Indication: An Exploration of Patients Anticoagulated for Atrial Fibrillation or Venous Thromboembolic Disease

A Comparison of Socioeconomic Factors in Patients Continuing Warfarin Versus Those Transitioning to Direct Oral Anticoagulants (DOACs) for Venous Thromboembolic Disease or Atrial Fibrillation

Biomarkers and Clinical Prediction Rules in the Diagnosis of Suspected Deep Vein Thrombosis: A Comparison of Cancer and Non-Cancer Patients

Improving Recognition, Diagnosis, and Management Of Heparin Induced Thrombocytopenia By Implementing a Computer-Based Clinical Decision Support System

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only